| When | | | Thursday, June | |
| | | | ||
| Where | | | The | |
| | | | ||
| Items of Business | | | We are holding the Annual Meeting for the following purposes, as more fully described in our proxy statement: 1. To elect 2. To ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 3. To transact any other business that properly comes before the Annual Meeting and at any adjournments and postponements thereof. | |
| | | | ||
| Record Date | | | Only stockholders of record at the close of business on April | |
| | | | ||
| How to Vote | | | Please vote your shares promptly to ensure the presence of a quorum at the Annual Meeting. Please review the proxy materials for the Annual Meeting and follow the instructions in the section entitled “Voting Information” of the accompanying Proxy Statement beginning on page 3 to vote. There will not be a physical meeting location, and stockholders will not be able to attend the Annual Meeting in person. As described on pages 5 and 6 of the accompanying Proxy Statement, any stockholder may attend the Annual Meeting online and vote during the online meeting even if he or she previously returned a proxy card by mail or voted via the Internet or by telephone. | |
| | | | By Order of the Board of Directors, | |
| | | | | |
| | | | Michael S. Turner | |
| | | | Vice President, General Counsel and Secretary | |
| Boston, Massachusetts | | | | |
| April 21, 2022 | | | | |
| | | Page | | |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 8 | | | |
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | |
Name | | | Positions and Offices held with 908 Devices | | | Director Since | | | Age | |
Fenel M. Eloi | | | Director | | | 2021 | | | 63 | |
Jeffrey P. George | | | Director | | | 2021 | | | 47 | |
Name | | | Positions and Offices held with 908 Devices | | | Director Since | | | Age | |
Kevin J. Knopp, Ph.D. | | | President, Chief Executive Officer and Director | | | 2012 | | | 49 | |
Tony J. Hunt | | | Director | | | 2022 | | | 58 | |
Mark Spoto | | | Director | | | 2012 | | | 53 | |
Name | | Positions and Offices held with 908 Devices | | Director Since | | Class and Year in Which Term Will Expire | | Age | | | Positions and Offices held with 908 Devices | | Director Since | | Class and Year in Which Term Will Expire | | Age | | ||||||||
Kevin J. Knopp, Ph.D. | | President, Chief Executive Officer and Director | | 2012 | | Class II - 2022 | | 48 | | |||||||||||||||||
Nicolas Barthelemy | | Director | | 2018 | | Class II - 2022 | | 55 | | |||||||||||||||||
Mark Spoto | | Director | | 2012 | | Class II - 2022 | | 52 | | |||||||||||||||||
Fenel M. Eloi | | Director | | 2021 | | Class I — 2024 | | 63 | | |||||||||||||||||
Jeffrey P. George | | Director | | 2021 | | Class I — 2024 | | 48 | | |||||||||||||||||
Keith L. Crandell | | Director | | 2012 | | Class III - 2023 | | 60 | | | Director | | 2012 | | Class III — 2023 | | 61 | | ||||||||
Marcia Eisenberg, Ph.D. | | Director | | 2021 | | Class III — 2023 | | 63 | | |||||||||||||||||
E. Kevin Hrusovsky | | Director | | 2013 | | Class III - 2023 | | 60 | | | Director | | 2013 | | Class III — 2023 | | 61 | |
Board Diversity Matrix (as of April 21, 2022) | | ||||||||||||||||||
Total Number of Directors – 9 | | | | | | | | | | | | | | | | | | | |
| | | Female | | | Male | | | Non-Binary | | | Did Not Disclose Gender | | ||||||
Part I: Gender Identity | | | | | | | | | | | | | | | | | | | |
Directors | | | | | 1 | | | | | | 8 | | | | | | | | |
Part II: Demographic Background | | | | | | | | | | | | | | | | | | | |
African American or Black | | | | | | | | | | | 1 | | | | | | | | |
Alaskan Native or Native American | | | | | | | | | | | | | | | | | | | |
Asian | | | | | | | | | | | | | | | | | | | |
Hispanic or Latinx | | | | | | | | | | | | | | | | | | | |
Native Hawaiian or Pacific Islander | | | | | | | | | | | | | | | | | | | |
White | | | | | 1 | | | | | | 7 | | | | | | | | |
Two or More Races or Ethnicities | | | | | | | | | | | | | | | | | | | |
LGBTQ+ | | | | | | | | | | | | | | | | | | | |
Did Not Disclose Demographic Background | | | | | | | | | | | | | | | | | | | |
Name | | Position held with 908 Devices | | Officer Since | | Age | | | Position held with 908 Devices | | Officer Since | | Age | | ||||||
Executive Officers | | | | | | | | | | | | | | | ||||||
Kevin J. Knopp, Ph.D. | | President, Chief Executive Officer and Director | | 2012 | | 48 | | | President, Chief Executive Officer and Director | | 2012 | | 49 | | ||||||
Christopher Brown, Ph.D. | | Chief Technology Officer | | 2012 | | 46 | | | Chief Technology Officer | | 2012 | | 47 | | ||||||
Joseph H. Griffith IV | | Chief Financial Officer | | 2014 | | 46 | | | Chief Financial Officer | | 2014 | | 47 | | ||||||
Trent Basarsky, Ph.D. | | Vice President, Corporate Development | | 2017 | | 53 | | | Vice President, Corporate Development | | 2017 | | 54 | | ||||||
John Kenneweg | | Vice President, Government | | 2013 | | 48 | | | Vice President, Government | | 2013 | | 49 | | ||||||
Michael S. Turner | | Vice President, General Counsel and Secretary | | 2020 | | 54 | | | Vice President, General Counsel and Secretary | | 2020 | | 55 | | ||||||
Key Senior Management | | | | | | | | | | | | | | | ||||||
Steve Davenport | | Vice President, Commercial Sales | | 2021 | | 55 | | | Vice President, Commercial Sales | | 2021 | | 56 | | ||||||
Maura Fitzpatrick | | Vice President, Product Management & Marketing | | 2020 | | 50 | | | Vice President, Product Management & Marketing | | 2020 | | 51 | | ||||||
Michele Fournier | | Chief People Officer | | 2021 | | 56 | | | Chief People Officer | | 2021 | | 57 | | ||||||
Kevin McCallion, Ph.D. | | Vice President, Production and New Product Introduction | | 2013 | | 55 | | | Vice President, Production and New Product Introduction | | 2013 | | 56 | |
Fee Category | | 2020 | | 2019 | | | 2021 | | 2020 | | ||||||||||||||||
Audit fees(1) | | | $ | 1,691,050 | | | | $ | 275,000 | | | | | $ | 1,010,474 | | | | $ | 1,691,050 | | | ||||
Audit-related fees(2) | | | | — | | | | | — | | | | | | — | | | | | — | | | ||||
Tax fees(3) | | | | 5,000 | | | | | — | | | | | | 12,000 | | | | | 5,000 | | | ||||
All other fees(4) | | | | 2,756 | | | | | — | | | | | | 2,956 | | | | | 2,756 | | | ||||
Total fees | | | $ | 1,698,806 | | | | $ | 275,000 | | | | | $ | 1,025,430 | | | | $ | 1,698,806 | | |
Name | | | Fees Earned or Paid In Cash ($)(1) | | | Option Awards ($)(2) (3) (4) | | | Total ($) | | |||||||||
Nicolas Barthelemy | | | | | 1,899 | | | | | | 291,728 | | | | | | 293,627 | | |
Keith L. Crandell | | | | | 2,205 | | | | | | 263,703 | | | | | | 265,908 | | |
E. Kevin Hrusovsky | | | | | 2,589 | | | | | | 218,794 | | | | | | 221,383 | | |
Sharon Kedar(5) | | | | | — | | | | | | — | | | | | | — | | |
J. Michael Ramsey, Ph.D.(6) | | | | | 61,438 | | | | | | 263,703 | | | | | | 325,141 | | |
Mark Spoto | | | | | 2,742 | | | | | | 263,703 | | | | | | 266,445 | | |
Name | | | Fees Earned or Paid In Cash ($)(1) | | | Stock Awards ($)(2) (3) (4) | | | Option Awards ($)(5) (6) (7) | | | All Other Compensation ($)(8) | | | Total ($) | | |||||||||||||||
Nicolas Barthelemy | | | | | 49,500 | | | | | | 57,504 | | | | | | 57,520 | | | | | | — | | | | | | 164,524 | | |
Keith L. Crandell | | | | | 57,000 | | | | | | 57,504 | | | | | | 57,520 | | | | | | — | | | | | | 172,024 | | |
Marcia Eisenberg, Ph.D.(9) | | | | | 21,094 | | | | | | 87,506 | | | | | | 87,514 | | | | | | — | | | | | | 196,114 | | |
Fenel M. Eloi(10) | | | | | 47,406 | | | | | | 145,031 | | | | | | 145,026 | | | | | | — | | | | | | 337,463 | | |
Jeffrey P. George(11) | | | | | 36,406 | | | | | | 145,031 | | | | | | 145,026 | | | | | | — | | | | | | 326,463 | | |
E. Kevin Hrusovsky | | | | | 67,500 | | | | | | 57,504 | | | | | | 57,520 | | | | | | — | | | | | | 182,524 | | |
Sharon Kedar(12) | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
J. Michael Ramsey, Ph.D.(13) | | | | | 18,626 | | | | | | — | | | | | | — | | | | | | 40,000 | | | | | | 58,626 | | |
Mark Spoto | | | | | 60,250 | | | | | | 57,504 | | | | | | 57,520 | | | | | | — | | | | | | 175,274 | | |
| | | Member Annual Retainer ($) | | | Chair Annual Retainer ($) | | ||||||
Board of Directors | | | | | 37,500 | | | | | | 25,000* | | |
Audit Committee | | | | | 9,000 | | | | | | 18,000 | | |
Compensation Committee | | | | | 6,000 | | | | | | 12,000 | | |
Nominating and Corporate Governance Committee | | | | | 5,000 | | | | | | 10,000 | | |
| | | Member Annual Retainer ($) | | | Chair Annual Retainer ($) | | ||||||
Board of Directors | | | | | 37,500 | | | | | | 25,000* | | |
Audit Committee | | | | | 9,000 | | | | | | 18,000 | | |
Compensation Committee | | | | | 6,000 | | | | | | 12,000 | | |
Nominating and Corporate Governance Committee | | | | | 5,000 | | | | | | 10,000 | | |
| | | Member Annual Retainer ($) | | | Chair Annual Retainer ($) | | ||||||
Board of Directors | | | | | 40,000 | | | | | | 40,000* | | |
Audit Committee | | | | | 10,000 | | | | | | 20,000 | | |
Compensation Committee | | | | | 10,000 | | | | | | 20,000 | | |
Nominating and Corporate Governance Committee | | | | | 7,500 | | | | | | 15,000 | | |
Name and principal position | | Year | | Salary ($) | | Option Awards ($)(1) | | Non-Equity Incentive Plan Compensation ($)(2) | | All Other Compensation ($)(3) | | Total ($) | | | Year | | Salary ($) | | Bonus ($)(1) | | Stock Awards ($)(2) | | Option Awards ($)(3) | | Non-Equity Incentive Plan Compensation ($)(4) | | All Other Compensation ($)(5) | | Total ($) | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kevin J. Knopp, Ph.D. President and Chief Executive Officer | | | | | 2020 | | | | | 284,431 | | | | | 218,794 | | | | | 87,082 | | | | | 238 | | | | | 590,545 | | | | | | | 2021 | | | | | 400,000 | | | | | 40,000 | | | | | — | | | | | — | | | | | 320,000 | | | | | — | | | | | 760,000 | | | ||||||||||||
| | | 2019 | | | | | 287,481 | | | | | 92,219 | | | | | 64,622 | | | | | 238 | | | | | 444,560 | | | | | | 2020 | | | | | 284,431 | | | | | — | | | | | — | | | | | 218,794 | | | | | 87,082 | | | | | 238 | | | | | 590,545 | | | |||||||||||||||
Christopher Brown, Ph.D. (6) Chief Technology Officer | | | | | 2021 | | | | | 300,000 | | | | | 30,000 | | | | | — | | | | | — | | | | | 120,600 | | | | | 2,427 | | | | | 453,027 | | | ||||||||||||||||||||||||||||||||||||||||||||
| | | 2020 | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||||||||||||||||||||||||||||||||||||
John Kenneweg Vice President, Government | | | | | 2020 | | | | | 205,974 | | | | | 65,638 | | | | | 300,878 | | | | | — | | | | | 572,490 | | | | | | | 2021 | | | | | 250,000 | | | | | — | | | | | 125,016 | | | | | 125,003 | | | | | 533,621 | | | | | — | | | | | 1,033,640 | | | ||||||||||||
| | | 2019 | | | | | 209,879 | | | | | 51,233 | | | | | 112,000 | | | | | — | | | | | 373,112 | | | | | | 2020 | | | | | 205,974 | | | | | — | | | | | — | | | | | 65,638 | | | | | 300,878 | | | | | — | | | | | 572,490 | | | |||||||||||||||
Michael S. Turner (4) Vice President, General Counsel and Secretary | | | | | 2020 | | | | | 81,732 | | | | | 544,522 | | | | | 16,104 | | | | | — | | | | | 642,358 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Name | | | Option Awards(1) | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Option Awards(1) | | Stock Awards(2) | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Name | | | Number of Securities Underlying Unexercised Options (#) Exercisable | | Number of Securities Underlying Unexercised Options (#) Unexercisable | | Option Exercise Price ($) | | Option Expiration Date | | | Number of Securities Underlying Unexercised Options (#) Exercisable | | Number of Securities Underlying Unexercised Options (#) Unexercisable | | Option Exercise Price ($) | | Option Expiration Date | | Number of Shares or Units of Stock That Have Not Vested (#) | | Market Value of Shares or Units of Stock That Have Not Vested ($)(3) | | |||||||||||||||||||||||||||||||||||||||
| | | 120,357(2) | | | | | 2,561(2) | | | | | 1.75 | | | | | 1/1/2027 | | | | | | | 122,918 | | | | | — | | | | | 1.75 | | | | | 1/1/2027 | | | | | — | | | | | — | | | ||||||||||
Kevin J. Knopp, Ph.D. | | | | | 53,015(3) | | | | | 57,611(3) | | | | | 1.58 | | | | | 1/21/2029 | | | | | | 80,674 | | | | | 29,952(4) | | | | | 1.58 | | | | | 1/21/2029 | | | | | — | | | | | — | | | |||||||||
| | | 7,682(4) | | | | | 115,236(4) | | | | | 3.24 | | | | | 9/21/2030 | | | | | | 38,412 | | | | | 84,506(5) | | | | | 3.24 | | | | | 9/21/2030 | | | | | — | | | | | — | | | |||||||||||
| | | | 122,918 | | | | | — | | | | | 1.75 | | | | | 1/1/2027 | | | | | — | | | | | — | | | |||||||||||||||||||||||||||||||
Christopher Brown, Ph.D. | | | | 44,815 | | | | | 16,644(4) | | | | | 1.58 | | | | | 1/21/2029 | | | | | — | | | | | — | | | |||||||||||||||||||||||||||||||
| | | 21,130 | | | | | 46,474(5) | | | | | 3.24 | | | | | 9/21/2030 | | | | | — | | | | | — | | | ||||||||||||||||||||||||||||||||
| | | | 153,033 | | | | | — | | | | | 0.35 | | | | | 4/18/2023 | | | | | | | 93,033 | | | | | — | | | | | 0.35 | | | | | 4/18/2023 | | | | | — | | | | | — | | | |||||||||
John Kenneweg | | | | 12,291 | | | | | — | | | | | 0.93 | | | | | 1/16/2025 | | | | | | 12,291 | | | | | — | | | | | 0.93 | | | | | 1/16/2025 | | | | | — | | | | | — | | | ||||||||||
| | | 27,656 | | | | | — | | | | | 0.96 | | | | | 12/2/2026 | | | | | | 27,656 | | | | | — | | | | | 0.96 | | | | | 12/2/2026 | | | | | — | | | | | — | | | |||||||||||
| | | 29,451(3) | | | | | 32,008(3) | | | | | 1.58 | | | | | 1/21/2029 | | | | | | 44,815 | | | | | 16,644(4) | | | | | 1.58 | | | | | 1/21/2029 | | | | | — | | | | | — | | | |||||||||||
| | | 2,307(5) | | | | | 34,568(5) | | | | | 3.24 | | | | | 9/14/2030 | | | | | | 11,531 | | | | | 25,344(6) | | | | | 3.24 | | | | | 9/14/2030 | | | | | — | | | | | — | | | |||||||||||
| | | 2,562(6) | | | | | 120,355(6) | | | | | 7.91 | | | | | 11/3/2030 | | | ||||||||||||||||||||||||||||||||||||||||||
John Kenneweg | | | | — | | | | | 8,702(7) | | | | | 24.00 | | | | | 12/1/2031 | | | | | — | | | | | — | | | |||||||||||||||||||||||||||||||
| | | | — | | | | | — | | | | | — | | | | | — | | | | | 5,209(8) | | | | | 134,757 | | |
Plan Category | | | Number of securities to be issued upon exercise of outstanding options (#) | | | Weighted- average exercise price of outstanding options ($) | | | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in first column) | | |||||||||
Equity compensation plans approved by security holders(1) | | | | | 3,405,698(2) | | | | | | 2.27 | | | | | | 2,170,121(3)(4) | | |
Equity compensation plans not approved by security holders | | | | | — | | | | | | — | | | | | | — | | |
Total | | | | | 3,405,698 | | | | | | 2.27 | | | | | | 2,170,121 | | |
Plan Category | | | Number of securities to be issued upon exercise of outstanding options, warrants and rights (#) | | | Weighted-average exercise price of outstanding options, warrants and rights ($)(3) | | | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in first column) (#)(4)(5) | | |||||||||
Equity compensation plans approved by security holders(1) | | | | | 2,934,805(2) | | | | | | 3.32 | | | | | | 1,969,178 | | |
Equity compensation plans not approved by security holders | | | | | — | | | | | | — | | | | | | — | | |
Total | | | | | 2,934,805 | | | | | | 3.32 | | | | | | 1,969,178 | | |
Name | | | Shares of Common Stock Purchased | | | Aggregate Cash Purchase Price | | ||||||
ARCH Venture Fund VII, L.P.(1) | | | | | 300,000 | | | | | $ | 6,000,000 | | |
Northpond Ventures, LP.(2) | | | | | 100,000 | | | | | | 2,000,000 | | |
E. Kevin Hrusovsky | | | | | 50,000 | | | | | | 1,000,000 | | |
Nicolas Barthelemy | | | | | 14,000 | | | | | | 280,000 | | |
Mark Spoto | | | | | 1,000 | | | | | | 20,000 | | |
Trent Basarsky, Ph.D. | | | | | 5,000 | | | | | | 100,000 | | |
Michael S. Turner | | | | | 5,000 | | | | | | 100,000 | | |
Total | | | | | 475,000 | | | | | $ | 9,500,000 | | |
Name and address of beneficial owner(1) | | | Shares Beneficially Owned | | |||||||||
| Number | | | Percentage | | ||||||||
> 5% Stockholders: | | | | | | | | | | | | | |
ARCH Venture Fund VII, L.P.(2) | | | | | 5,725,045 | | | | | | 21.0% | | |
Razor’s Edge Funds(3) | | | | | 1,943,641 | | | | | | 7.1% | | |
Directors and Named Executive Officers | | | | | | | | | | | | | |
E. Kevin Hrusovsky(4) | | | | | 527,910 | | | | | | 1.9% | | |
Nicolas Barthelemy(5) | | | | | 101,090 | | | | | | * | | |
Keith L. Crandell(6) | | | | | 5,725,447 | | | | | | 21.0% | | |
Fenel M. Eloi(7) | | | | | 285 | | | | | | * | | |
Jeffrey P. George(8) | | | | | 285 | | | | | | * | | |
Sharon Kedar(9) | | | | | 1,077,091 | | | | | | 3.9% | | |
J. Michael Ramsey, Ph.D.(10) | | | | | 1,601,100 | | | | | | 5.9% | | |
Mark Spoto(11) | | | | | 1,947,043 | | | | | | 7.1% | | |
Kevin J. Knopp, Ph.D.(12) | | | | | 1,565,871 | | | | | | 5.7% | | |
John Kenneweg(13) | | | | | 237,034 | | | | | | * | | |
Michael S. Turner(14) | | | | | 22,929 | | | | | | * | | |
Directors and Executive Officers as a group (14 persons)(15) | | | | | 14,652,321 | | | | | | 51.1% | | |
| | | Shares Beneficially Owned | | |||||||||
Name and address of beneficial owner(1) | | | Number | | | Percentage | | ||||||
> 5% Stockholders: | | | | | | | | | | | | | |
ARCH Venture Fund VII, L.P.(2) | | | | | 5,725,045 | | | | | | 18.2% | | |
BlackRock, Inc.(3) | | | | | 3,709,061 | | | | | | 11.8% | | |
ARK Investment Management LLC(4) | | | | | 3,131,383 | | | | | | 10.0% | | |
Directors and Named Executive Officers | | | | | | | | | | | | | |
E. Kevin Hrusovsky(5) | | | | | 558,327 | | | | | | 1.8% | | |
Nicolas Barthelemy(6) | | | | | 103,346 | | | | | | * | | |
Keith L. Crandell(7) | | | | | 5,734,100 | | | | | | 18.3% | | |
Marcia Eisenberg, Ph.D.(8) | | | | | 1,852 | | | | | | * | | |
Fenel M. Eloi(9) | | | | | 3,826 | | | | | | * | | |
Jeffrey P. George(10) | | | | | 3,826 | | | | | | * | | |
Tony J. Hunt(11) | | | | | 864 | | | | | | * | | |
Mark Spoto(12) | | | | | 49,113 | | | | | | * | | |
Kevin J. Knopp, Ph.D.(13) | | | | | 1,526,950 | | | | | | 4.8% | | |
Christopher Brown, Ph.D.(14) | | | | | 1,162,799 | | | | | | 3.7% | | |
John Kenneweg(15) | | | | | 160,455 | | | | | | * | | |
Directors and Executive Officers as a group (14 persons)(16) | | | | | 9,696,698 | | | | | | 29.8% | | |